Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: UK PM faces battle over "un-British" vaccine passports

Wed, 07th Apr 2021 06:50

(Alliance News) - UK Prime Minister Boris Johnson faces a battle to introduce domestic vaccine passports after running into fierce opposition from Tory critics and Labour.

A government review into "Covid status certification" found they could "potentially play a role" in settings such as theatres, nightclubs and mass events, and might also be used in pubs and restaurants to reduce social distancing restrictions.

The prospect of having to show a certificate to access shops or bars has outraged members of the Covid Recovery Group of Conservatives, while Labour hit out at the "discriminatory" and "poorly thought-through" proposals.

The use of certificates – which would include vaccination status, test results or evidence of someone having contracted and recovered from Covid-19 – is opposed by at least 40 Conservative MPs.

With Labour's opposition also hardening, along with the SNP raising concerns, the government would face difficulties in getting the measures through the Commons if Johnson pushed them to a vote.

Ministers have ruled out bringing in certification for either the April 12 or May 17 stages of the road map but the documents – either in paper form or on an NHS app – could be introduced later this year.

Johnson suggested that vaccination passports for overseas travel were "going to be a fact of life" because a lot of countries were looking at the possibility.

On the domestic front, he indicated "we are also going to look at the role of a number of signals that you can give that you are not contagious", highlighting the role for mass testing.

"From Friday, everybody can get free lateral flow tests on the NHS and on the web, over the internet," he said.

"I think that will also be very, very valuable in giving people confidence to open up."

Tory former minister Steve Baker, the deputy chairman of the CRG, said the requirement to show documents would be "un-British".

The government's review suggested that if an official system is not introduced, firms would be able to ask customers for proof of Covid status in order to access their premises anyway.

But Baker said: "Whether the government imposes this, recommends it or simply stands back and allows it to happen, Covid status certification would be entirely un-British and our country and values would become unrecognisable."

He warned the country could be changed forever into the "miserable dystopia of Checkpoint Britain".

The interim findings of the government's review said public transport and essential shops or services would not require vaccine passports.

But that left open the prospect of non-essential retail outlets being forced to check on their customers.

Shadow health secretary Jonathan Ashworth told the BBC: "I'm not going to support a policy that, here in my Leicester constituency, if someone wants to go into Next or H&M, they have to produce a vaccination certificate on their phone, on an app.

"I think that's discriminatory."

A senior Labour source said: "On the basis of what we've seen and discussed with ministers, we oppose the government's plans for domestic vaccine passports.

"They appear poorly thought-through, will put added burdens on business and run the risk of becoming another expensive Whitehall project that gets outsourced to friends of Tory ministers."

The SNP's Westminster leader, Ian Blackford, said the ministers must address the "considerable issues" on "equity, ethics and privacy".

"The UK Government hasn't published any proposals yet, and the Tory position has been mired in confusion and contradiction. On the basis of the information available, there is not a proposition in front of us that SNP MPs could support," he said.

"While there might be a need to consider means to facilitate international travel, any such proposals must only be agreed in consultation with the devolved governments."

In other developments:

– The trial of the Oxford University and AstraZeneca PLC vaccine in children was paused while regulators investigate reports of a rare form of blood clot among adults, but the university stressed that no safety concerns have arisen from the trial itself.

– Secondary school and college pupils in England will need to continue wearing face masks in class when they return after Easter as a precautionary measure.

– The Valneva Covid-19 vaccine, which is set to be manufactured in the UK, produces a "strong immune response", Health Secretary Matt Hancock said following promising results in an early-stage phase one/two study involving 153 people.

– The prime minister suggested he was considering allowing travellers returning from low-risk countries to take cheap and fast lateral flow tests rather than the more expensive PCR alternative.

– All pupils across Scotland, except those who are shielding, will be back in the classroom full-time following the Easter holidays.

– A further 20 people were reported to have died within 28 days of testing positive for Covid-19 as of Tuesday, bringing the UK total by that measure to 126,882.

– Figures to April 5 showed 31.6 million have received a first dose of vaccine, a rise of 40,744 on the previous day, while 5.5 million have also been given a second jab, an increase of 64,590.

Meanwhile, the prime minister insisted he would not deviate from his road map out of lockdown despite warnings from scientific advisers that the plan could result in a third wave of coronavirus cases and deaths.

The Scientific Pandemic Influenza Group on Modelling, which advises the government, produced a paper dated March 31 suggesting later stages of the road map out of lockdown was "highly likely" to lead to increased hospital cases and deaths.

Speaking to reporters during a visit to an AstraZeneca plant in Macclesfield, Johnson said: "At the moment, as I look at all the data, I can't see any reason for us to deviate from the road map that we have set out, we are sticking to it."

Further relaxations of restrictions in England are pencilled in for May 17 and June 21.

Johnson has already confirmed April 12 will see the next step along the road map, with shops, pub beer gardens, gyms and hairdressers among premises allowed to reopen.

By David Hughes, PA Political Editor

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more
30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

Read more
29 May 2024 08:54

IN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trial

AstraZeneca PLC - Cambridge, England-based pharmaceuticals - Reports positive results in a phase 1 trial of cholesterol drug candidate AZD0780, an oral small molecule PCSK9 inhibitor. Administered on top of rosuvastatin treatment, AZD0780 showed a statistically significant reduction in low-density lipoprotein cholesterol in plasma for test participants with hypercholesterolaemia, Astra says, while no serious adverse events were reported. "Elevated LDL-C levels in plasma is a key risk factor for cardiovascular disease and is estimated to cause 2.6 million deaths worldwide annually," Astra notes.

Read more
28 May 2024 07:02

AstraZeneca experimental lung cancer drug shows promising results

(Sharecast News) - AstraZeneca's experimental lung cancer drug showed improved overall survival rates in phase III trials, the pharmaceutical giant said on Tuesday.

Read more
27 May 2024 07:49

IN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXd

AstraZeneca PLC - Cambridge, UK-based pharmaceutical firm - Alongside Japan's Daiichi Sankyo Co Ltd, notes positive data for datopotamab deruxtecan in phase III trial on lung cancer. Says the treatment, also known as Dato-DXd, showed a clinically meaningfully improvement in overall survival versus chemotherapy in advanced nonsquamous non-small cell lung cancer. The results build upon the positive progression-free survival findings presented back in 2023, Astra adds.

Read more
22 May 2024 09:53

LONDON BROKER RATINGS: Barclays cuts NextEnergy but lifts JLEN

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
22 May 2024 02:00

British firms expecting hard time in China market, lobby group warns

BEIJING, May 22 (Reuters) - British firms expect doing business in China to become harder over the next five years, a British business lobby group said on Wednesday, as Beijing strives to halt a retreat in foreign funds from a market once seen as the engine of global growth.

Read more
21 May 2024 19:00

Sector movers: Stocks slip amid light profit-taking

(Sharecast News) - Stocks ended a tad lower as investors waited on a raft of US central bank speakers scheduled for after the close of markets in London.

Read more
21 May 2024 17:20

Europe's STOXX 600 ends lower as rate uncertainty prevails

Focus on Fed minutes, Nvidia earnings

*

Read more
21 May 2024 17:04

LONDON MARKET CLOSE: London dips as eyes turn to UK inflation reading

(Alliance News) - Stock prices in London closed in the red on Tuesday, as investors nervously eye a key UK inflation reading, which could prompt the Bank of England to consider interest rate cuts.

Read more
21 May 2024 15:00

London close: Stocks fall ahead of key inflation reading

(Sharecast News) - London stocks ended in negative territory on Tuesday, influenced by the latest UK economic outlook from the International Monetary Fund (IMF) and comments from US Federal Reserve officials.

Read more
21 May 2024 12:03

CORRECT: Stocks fall but pound up as IMF ups UK forecast

(Correcting London Stock Exchange index prices.)

Read more
21 May 2024 12:00

LONDON MARKET MIDDAY: Stocks fall but pound up as IMF ups UK forecast

(Alliance News) - Stock prices in Europe were lower heading into Tuesday afternoon, with shares in New York also set for a muted open, as a recent rally for equities takes a pause.

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 09:04

LONDON MARKET OPEN: FTSE 100 declines after Asian stocks fall

(Alliance News) - Stock prices in London opened in the red on Tuesday, with some US interest rate cut optimism cooling after hawkish words from Federal Reserve central bankers.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.